Chronic Kidney Disease (CKD) Drugs Market, Growth, Analysis and Forecast 2017 -Posted by akshayparmar on November 3rd, 2017 Chronic Kidney Disease (CKD) Drugs Market - Growth, Future Prospects and Competitive Analysis, 2017 - 2025 the global Chronic Kidney Disease (CKD) Drugs market was valued at US$ 12.88 Bn in 2017, and is expected to reach US$ 17.4 Bn by 2025, expanding at a CAGR of 3.9% from 2017 to 2025. Browse Full Report Visit - http://www.acutemarketreports.com/report/chronic-kidney-disease-ckd-drugs-market Market Insights Chronic Kidney Disease (CKD) is also known as chronic kidney failure characterized by gradual loss of kidney function. There are different types of medications available in market. Medicines cannot reverse CKD, however they are used to treat complications and to slow further kidney damage. Factors such as rising incidence of cardiovascular disorders and diabetes, increasing geriatric population, significant unmet needs, promising pipeline molecule such as ABT-614 (Abbott laboratories), EOS789 (Chugai Pharmaceutical) and increasing prevalence of CKD would further drive the growth of CKD drugs market globally. However, preferable use of generic drugs and in some countries may negatively impacting the market growth. Market Competition Assessment: The Chronic Kidney Disease (CKD) Drugs market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as AbbVie, Inc., Allergan plc. Amgen Inc., AstraZeneca plc., F. Hoffmann-La Roche Ltd, FibroGen, GlaxoSmithKline plc., Johnson & Johnson, Keryx Biopharmaceuticals, Inc., Kissei Pharmaceutical Co. Ltd., Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd. and other. Key Market Movements: • Factors such as rising incidence of CKD, increasing geriatric population, favorable reimbursement policies in some countries and high degree of R&D activity in development of CKD drugs are driving the market growth globally.
Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Chronic Kidney Disease (CKD) Drugs Market Analysis Chapter 4 Global Chronic Kidney Disease (CKD) Drugs Market, by Drug Class About - Acute Market Reports : Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online. Name : Chris Paul ACUTE MARKET REPORTS Designation : Global Sales Manager Toll Free(US/CANADA): +1-855-455-8662 Email : sales@acutemarketreports.com Website :http://www.acutemarketreports.com Like it? Share it!More by this author |